In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
  • Select congresses

    Select Select congresses(s)

  • Year

    Select Year(s)

  • Resource type

    Select Resource type(s)

  • Topic

    Select Topic(s)

Filters (0)
  • Select congresses
  • sub-topic
  • Year
  • Resource type
  • Topic
  • Select congresses
  • sub-topic
  • Year
  • Resource type
  • Topic

80 results for your search

Implementation of guidelines - Practicalities of giving intravenous (IV) iron.

Congress : EuroHeartCare 2018

  • Session : Iron deficiency and heart health
  • Speaker : N Caples (Waterford,IE)
  • Sponsored by Vifor Pharma UK Ltd

Opening remarks.

Congress : EuroHeartCare 2018

  • Session : Iron deficiency and heart health
  • Speaker : N Murphy (Dublin,IE)
  • Sponsored by Vifor Pharma UK Ltd

Panel discussion.

Congress : Heart Failure 2018

  • Session : Dilemma in cardio-renal patients: hyperkalaemia vs renin-angiotensin-aldosterone system inhibitors?
  • Speaker : J Butler (Atlanta,US)
  • Sponsored by Vifor Pharma

Introduction - Dilemma in cardio-renal patients: hyperkalaemia vs renin-angiotensin-aldosterone system inhibitors therapy.

Congress : Heart Failure 2018

  • Session : Dilemma in cardio-renal patients: hyperkalaemia vs renin-angiotensin-aldosterone system inhibitors therapy
  • Speaker : B Pitt (Ann Arbor,US)
  • Sponsored by Vifor Pharma

Changing the treatment paradigm of hyperkalaemia management to enable and optimize renin-angiotensin-aldosterone system inhibitors therapy.

Congress : Heart Failure 2018

  • Session : Dilemma in cardio-renal patients: hyperkalaemia vs renin-angiotensin-aldosterone system inhibitors?
  • Speaker : B Pitt (Ann Arbor,US)
  • Sponsored by Vifor Pharma

Identifying iron deficiency in practice: understanding the correct diagnosis of iron deficiency in heart failure patients.

Congress : Heart Failure 2018

  • Session : Iron deficiency: an important comorbidity
  • Speaker : EA Jankowska (Wroclaw,PL)
  • Sponsored by Vifor Pharma

Practical implementation of The ESC 2016 Heart Failure Guidelines: management of iron deficiency - Conclusion.

Congress : Heart Failure 2018

  • Session : Practical implementation of The ESC 2016 Heart Failure Guidelines: management of iron deficiency
  • Speaker : M Boehm (Homburg,DE)
  • Sponsored by Vifor Pharma

Managing iron deficiency: a practical approach.

Congress : Heart Failure 2018

  • Session : Iron deficiency: an important comorbidity
  • Speaker : CS Lam (Singapore,SG)
  • Sponsored by Vifor Pharma

The ESC 2016 Heart Failure Guidelines: what is the recommendation for iron deficiency and why?

Congress : Heart Failure 2018

  • Session : Iron deficiency: an important comorbidity
  • Speaker : S Anker (Berlin,DE)
  • Sponsored by Vifor Pharma

Iron deficiency in heart failure: future directions.

Congress : Heart Failure 2018

  • Session : Iron deficiency in heart failure: future directions
  • Speaker : S Anker (Berlin,DE)
  • Sponsored by Vifor Pharma

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are